A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China.
Front Neurol
; 14: 1103164, 2023.
Article
en En
| MEDLINE
| ID: mdl-36891473
ABSTRACT
Background:
Although Parkinson's disease (PD) is the second most common neurodegenerative disorder, pregnancy in patients with PD is a relatively rare occurrence because the most common age of onset of PD is beyond the childbearing age, except in patients with Young-Onset PD (YOPD) caused by parkin RBR E3 ubiquitin protein ligase (PRKN) mutations. Case In this study, we report the case of a 30-year-old Chinese woman who was affected by PRKN-associated YOPD and was treated with levodopa/benserazide during pregnancy. She gave birth to a healthy baby boy with an Apgar score of 9 through an uncomplicated vaginal delivery.Conclusion:
This case further suggests that levodopa/benserazide during pregnancy is safe in the treatment of PRKN-associated YOPD.
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Año:
2023
Tipo del documento:
Article